Skip to main content
CBIO logo

CBIO · Crescent Biopharma, Inc. · Short Interest

Track CBIO — free
$13.00 +0.09 (+0.70%) At close · Nov 20
Market Cap
$505.64M
Shares
38.90M
Volume · Nov 20 422.38K Avg daily vol (3M) 358.97K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

CBIO Latest Reported Short Interest

FINRA reported 4,160,829 CBIO shares sold short as of the October 30, 2026 settlement date, a decrease of 258,356 shares. Days to cover was 16.29 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

CBIO Short Interest Forecast

Equibles' model estimates 4,269,678 shares sold short for the November 13, 2026 settlement, +2.6% versus the latest reported position, with a likely range of 3,959,048 to 4,617,388 shares. This model prediction uses FINRA data through November 13, 2026; FINRA's official release is expected November 24, 2026.

Model estimate

Expected Nov 13 short interest

as of Nov 13 High confidence 63% chance it rises
4,269,678 +2.6% vs reported
Likely range 3,959,048 to 4,617,388 The latest estimate appears in the chart below. Official release expected Nov 24. Methodology
Short Squeeze Score
77/100
Short interest 10.7% of shares — P90 Days to cover 16.3 — P96 Price vs VWAP -16.3% — P42 Short-volume trend +18.6% — P94 Short interest change -5.8% — P34 Worst FTD 0.04% of shares — P74

Positioning score 77.3 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-11-21 08:21 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-11-30 Scheduled
FINRA publishes Dec 9
— — — —
2026-11-13 Scheduled
FINRA publishes Nov 24
— — — —
2026-10-30 4,160,829 4,419,185 -258,356 16.29
2026-10-15 4,419,185 4,777,172 -357,987 12.66
2026-09-30 4,777,172 3,407,158 +1,370,014 6.85
2026-09-15 3,407,158 3,172,374 +234,784 8.51
2026-08-31 3,172,374 3,216,698 -44,324 19.91
2026-08-14 3,216,698 3,465,334 -248,636 17.13
2026-07-31 3,465,334 3,743,278 -277,944 8.92
2026-07-15 3,743,278 3,673,343 +69,935 9.73
2026-06-30 3,673,343 3,346,536 +326,807 7.03
2026-06-15 3,346,536 3,257,490 +89,046 15.76
2026-05-29 3,257,490 2,901,354 +356,136 11.27
2026-05-15 2,901,354 2,395,086 +506,268 8.42
2026-04-30 2,395,086 2,228,407 +166,679 8.87
2026-04-15 2,228,407 2,238,781 -10,374 8.73
2026-03-31 2,238,781 1,447,809 +790,972 9.07
2026-03-13 1,447,809 1,445,957 +1,852 9.74
2026-02-27 1,445,957 1,265,783 +180,174 8.80
2026-02-13 1,265,783 1,113,469 +152,314 5.03
2026-01-30 1,113,469 896,595 +216,874 5.43
2026-01-15 896,595 794,628 +101,967 7.70
2025-12-31 794,628 794,227 +401 8.62
2025-12-15 794,227 562,655 +231,572 2.49
2025-11-28 562,655 580,842 -18,187 11.61

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1253689 CUSIP G2545C104 13F (30d) 102 filings 99 filers Visit website Investor relations